Logo Passei Direto
Buscar
Material
páginas com resultados encontrados.
páginas com resultados encontrados.

Prévia do material em texto

Leitura obrigatória 
 
1. Instituto para Práticas Seguras no Uso de Medicamentos. Desafio Global de 
Segurança do Paciente – Medicação sem danos [Internet]. Boletim ISMP Brasil. 
2018;7(1):1-8. [acesso em junho 2023]. Disponível em: https://www.ismp-
brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf 
2. World Health Organization. (2019). Medication safety in polypharmacy: technical 
report. World Health Organization. https://apps.who.int/iris/handle/10665/325454. 
Licença: CC BY-NC-SA 3.0 IGO 
3. World Health Organization. (2019). Medication safety in transitions of care: 
technical report. World Health Organization. 
https://apps.who.int/iris/handle/10665/325453. Licença: CC BY-NC-SA 3.0 IGO 
4. World Health Organization. (2019). Medication safety in high-risk situations. World 
Health Organization. https://apps.who.int/iris/handle/10665/325131. Licença: CC 
BY-NC-SA 3.0 IGO 
5. Instituto para Práticas Seguras no Uso de Medicamentos. Polifarmácia: Quando 
muito é demais? [Internet]. Boletim ISMP Brasil. 2018;7(3):1-8. [acesso em junho 
2023]. Disponível em: https://www.ismp-brasil.org/site/wp-
content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf 
6. Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos 
potencialmente perigosos de uso ambulatorial e para instituições de longa 
permanência - listas atualizadas 2022 [Internet]. Boletim ISMP Brasil. 
2022;11(1):1-9. [acesso em junho 2023]. Disponível em: https://www.ismp-
brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-
POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf 
7. Instituto para Práticas Seguras no Uso de Medicamentos. Medicamentos 
potencialmente perigosos de uso hospitalar - lista atualizada 2019 [Internet]. 
Boletim ISMP Brasil. 2019;8(1):1-9. [acesso em junho 2023]. Disponível em: 
https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP-
FEVEREIRO-2019.pdf 
8. Instituto para Práticas Seguras no Uso de Medicamentos. Uso seguro de 
medicamentos por pacientes com doença renal crônica [Internet]. Boletim ISMP 
Brasil. 2021;10(5):1-10. [acesso em junho 2023]. Disponível em: 
https://www.ismp-brasil.org/site/wp-
content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf 
9. Instituto para Práticas Seguras no Uso de Medicamentos. Prevenção de erros de 
medicação na transição do cuidado [Internet]. Boletim ISMP Brasil. 2019;8(2):1-
11. [acesso em junho 2023]. Disponível em: https://www.ismp-brasil.org/site/wp-
content/uploads/2019/04/boletim_ismp_30a_edicao.pdf 
10. Instituto para Práticas Seguras no Uso de Medicamentos. Estratégias para 
envolver o paciente na prevenção de erros de medicação [Internet]. Boletim ISMP 
Brasil. 2019;8(3):1-9. [acesso em junho 2023]. Disponível em: https://www.ismp-
brasil.org/site/wp-
content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_
Brasil.pdf 
https://www.ismp-brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2018/02/ISMP_Brasil_Desafio_Global.pdf
https://apps.who.int/iris/handle/10665/325454
https://apps.who.int/iris/handle/10665/325453
https://apps.who.int/iris/handle/10665/325131
https://www.ismp-brasil.org/site/wp-content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2018/12/BOLETIM-ISMP-NOVEMBRO.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2022/09/MEDICAMENTOS-POTENCIALMENTE-PERIGOSOS-LISTAS-ATUALIZADAS-2022.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP-FEVEREIRO-2019.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/02/BOLETIM-ISMP-FEVEREIRO-2019.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2021/10/Boletim_outubro_2021_doenca_renal_cronica.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/04/boletim_ismp_30a_edicao.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/04/boletim_ismp_30a_edicao.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf
https://www.ismp-brasil.org/site/wp-content/uploads/2019/05/Estrategias_para_envolver_o_paciente_Boletim_ISMP_Brasil.pdf
 
 
 
 
Leitura complementar sugerida 
 
1. MIRA JJ et al. A systematic review of patient medication error on self-administering 
medication at home. Expert Opin Drug Saf 2015;14(6):815–38. 
2. Cadogan CA, Ryan C, Hughes CM. Appropriate Polypharmacy and Medicine 
Safety: When Many is not Too Many. Drug Saf 2016;39:109–16. 
3. Lee EA et al. Refining the Definition of Polypharmacy and Its Link to Disability in 
Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary 
Polypharmacy, and Polypharmacy of Unclear Benefit. The Permanente journal 
2020;24(18):1-6. 
4. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of 
definitions, epidemiology and consequences. European geriatric medicine 
2021;12(3):443–52. 
5. American Geriatrics Society Beers Criteria® Update Expert Panel. American 
Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate 
medication use in older adults. J Am Geriatr Soc. 2023 May 4. doi: 
10.1111/jgs.18372. 
6. Morin L et al. Adequate, questionable, and inadequate drug prescribing for older 
adults at the end of life: a European expert consensus. Eur J Clin Pharmacol 
2018;74:1333–42. 
7. Lindsay J et al. The development and evaluation of an oncological palliative care 
deprescribing guideline: the 'OncPal deprescribing guideline'. Support Care 
Cancer. 2015 Jan;23(1):71-8. 
8. Thompson J. Deprescribing in palliative care. Clin Med (Lond). 2019 Jul;19(4):311-
4. 
9. Hedman C, Frisk G, Björkhem-Bergman L. Deprescribing in Palliative Cancer 
Care. Life. 2022; 12(5):613. 
10. Souza BG et al. Eventos adversos a medicamentos entre idosos no Brasil antes 
e após o início da pandemia da COVID-19. Vigil Sanit Debate 2022;10(3):13-21. 
11. Zulman DM et al. Examining the evidence: a systematic review of the inclusion and 
analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011 
Jul;26(7):783-90. 
12. Kochar B et al. Systematic Review of Inclusion and Analysis of Older Adults in 
Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel 
Diseases. Inflamm Bowel Dis. 2021 Aug 19;27(9):1541-1543. 
13. PageII RL et al. Drugs That May Cause or Exacerbate Heart Failure. Circulation 
2016;134(6): e32–e69. 
14. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic 
dysfunction. Eur J Clin Pharmacol 2008;64:1147–61. 
15. Knight DA et al. ‘Seamless care? Just a list would have helped!’ Older people and 
their carer’s experiences of support with medication on discharge home from 
hospital. Health Expectations 2011;16(3):277-91. 
 
 
 
 
 
 
 
16. Sawan MJ et al. Caregivers' experiences of medication management advice for 
people living with dementia at discharge. Journal of Evaluation in Clinical Practice 
2021;27(6):1252-61. 
17. Schlögl M et al. Communication during the COVID-19 pandemic: evaluation study 
on self-perceived competences and views of health care professionals. Eur Geriatr 
Med. 2021 Dec;12(6):1181-90. 
18. Pantuzza LLN et al. Mapping the construct and measurement of medication 
literacy: a scoping review. Br J Clin Pharmacol. 2021;87:754–75.19. Neiva Pantuzza LL et al. Medication literacy: A conceptual model. Res Social Adm 
Pharm. 2022 Apr;18(4):2675-82. 
20. Pantuzza LLN et al. Development and content validation of the medication literacy 
test for older adults (TELUMI), Archives of Gerontology and Geriatrics 023 
Sep;112:105027. 
21. Rezende CP et al. Family caregivers’ experience in the process of caring for older 
adults: a qualitative synthesis. RESEARCH, SOCIETY AND DEVELOPMENT 
2021;10:e27101220037. 
22. Cruzeiro MGM et al. Experience in caring for the older people with dementia in the 
home environment: a qualitative synthesis of evidence. Revista de Pesquisa: 
Cuidado é Fundamental (Online) 2022;14:1-9. 
	Leitura obrigatória

Mais conteúdos dessa disciplina